The MarketWatch News Department was not involved in the creation of this content. DELRAY BEACH, Fla., Aug. 27, 2025 /PRNewswire/ -- The global Protein A Resin Market, valued at US$1.4 billion in 2024, ...
Biomanufacturers face the ongoing challenge of balancing costs and production timelines, with product quality and purity. Join us for this insightful webinar to explore the latest innovations for ...
Acquisition aims to strengthen company’s downstream process offering of advanced filtration and chromatography solutions JSR’s innovative Amsphere™ Protein A resin technology complements the company’s ...
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new research paper from its global research and development Center (R&D ...
As monoclonal antibody (mAb) titers increase to multi-gram-per-liter ranges, downstream purification is increasingly strained. Protein A affinity chromatography is the industry standard for initial ...
Nagase Viita is building on its rich history in saccharide innovation to improve antibody production. The company provides a stable and sustainable global supply of high-quality injectable-grade ...
A number of blockbuster biologics worth $200 billion in revenue are expected to lose patent exclusivity by 2030 (1), which presents biosimilar manufacturers a huge opportunity for producing drugs at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback